Providing Postmarketing Periodic Safety Reports
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled “Providing Postmarketing Periodic Safety Reports in the ICH E2C(R2) Format (Periodic Benefit-Risk Evaluation Report).”
